Table 1.
Baseline Characteristics of the Intervention and Control Group Patients
| Control (n=18) | Experiment (n=22) | p-value | |
|---|---|---|---|
| Age (years) | 65.39 ± 2.44a | 63.64 ± 1.79 | 0.558§ |
| Height (cm) | 160.87 ± 2.29 | 164.22 ± 1.19 | 0.206§ |
| Body weight before diagnosis (kg) | 61.86 ± 2.30 | 64.88 ± 1.76 | 0.296§ |
| Body weight change‡ (%) | -5.06 ± 0.65 | -6.01 ± 0.99 | 0.392¶ |
| Sex , no. of subjects (%) | |||
| Male | 13 (72.2)b | 19 (86.4) | 0.430†† |
| Female | 5 (27.8) | 3 (13.6) | |
| Diagnosis site, no. of subjects (%)†† | |||
| Esophagus | 1 (5.6) | 1 (4.5) | 0.092†† |
| Gallbladder | 0 (0.0) | 3 (13.7) | |
| Duodenum | 1 (5.6) | 1 (4.6) | |
| Pancreas | 5 (27.8) | 3 (13.6) | |
| Stomach | 4 (22.2) | 6 (27.3) | |
| Colon | 3 (16.7) | 8 (36.4) | |
| Cecum | 1 (5.6) | 0 (0.0) | |
| Rectum | 3 (16.7) | 0 (0.0) | |
| Cancer stage, no. of subjects (%)†† | |||
| Stage II | 2 (11.1) | 2 (9.1) | 0.397†† |
| Stage III | 3 (16.7) | 8 (36.4) | |
| Stage IV | 13 (72.2) | 12 (54.5) | |
| Treatment, no. of subjects (%)†† | |||
| Chemotherapy | 10 (55.6) | 16 (72.7) | 0.363†† |
| Chemo+Radiation | 0 (0.0) | 1 (4.6) | |
| Surgery | 1 (5.6) | 0 (0.0) | |
| Chemo+Surgery | 6 (33.2) | 5 (22.7) | |
| Chemo+Radiation+Surgery | 1 (5.6) | 0 (0.0) | |
| Smoking, no. of subjects (%)†† | |||
| Never | 8 (44.4) | 8 (36.4) | 0.545†† |
| Former | 8 (44.4) | 10 (45.5) | |
| Current | 2 (11.1) | 4 (18.2) | |
| Drinking, no. of subjects (%)†† | |||
| Never | 6 (33.3) | 8 (36.4) | 0.242†† |
| Former | 9 (50.0) | 13 (59.1) | |
| Current | 3 (16.7) | 1 (4.5) | |
| Supplement, no. of subjects (%)†† | |||
| Yes | 0 (0.0) | 3 (13.6) | 0.238†† |
| No | 18 (100.0) | 19 (86.4) | |
| ECOG (Pateient performance status) | 0.89 ± 0.14 | 1.00 ± 0.17 | 0.760¶ |
a, Data for age, body weight and sex are mean ± SD (control n=18, experimental n=22); b, Data for diagnostic site, cancer stage, treatment, smoking, drinking, supplement, and ECOG are numbers (%) of subjects; §, p-value for differences between two groups were calculated by Student’s t-test; ¶, p-value for differences between two groups were calculated by Mann-Whitney U test; ††, p -value for differences between two groups were calculated by Fisher test; Abbreviation: EGOC-Eastern Cooperative Oncology Group